Aslani, Jack Perez .
HRN: 22-76-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
10/22/2025
10/29/2025
PO
3ml
BID
PCAP With HRAD
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes